ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

In Brief: Jack McShulkis Dies Following Stroke; Congress Gives Final Approval to Appropriations Bill

October 28, 1983

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

Autologous BMT Equivalent To Allogeneic For Myeloma

December 31, 2010

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004

Waksal Pleads Guilty To Securities Fraud

October 18, 2002